Diagnosing the Future: The Impact of the COVID-19 Pandemic on Diagnostics

12:00 PM - 12:45 PM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies

The COVID-19 pandemic has highlighted the critical public health role for rapid, accurate and accessible diagnostic technologies as a tool in the fight to save lives. Now in the spotlight, the diagnostics industry has a chance to reframe its future to better navigate challenges such as uncertain market conditions, uncertain regulatory environment, payer skepticism, clinical education, patient education and an overburdened lab community.

This session will examine how diagnostics played a significant role in the COVID-19 pandemic, including lessons learned, then transitioning to a discussion on the future for diagnostics in healthcare. The panel will also explore how the US can better utilize a sustainable investment model that promotes innovation in this field to ensure that we have the diagnostics capabilities and infrastructure to better detect, diagnose and guide treatment decisions for all diseases, but especially to prepare for future public health threats.

Moderator
photo
Assistant Research Professor at the Center for Global Health Science and Security
Georgetown University
Speakers
photo
Assistant Research Professor at the Center for Global Health Science and Security
Georgetown University
photo
Co-Founder, CEO, President & Director
Sherlock Biosciences
photo
Deputy Director
NIBIB/NIH
photo
Chief, Multiplex Diagnostics Branch
BARDA, HHS
photo
Director, Federal Health Policy & Reimbursement
Roche